GRAVITY ( NCT@ ) compared efficacy , safety and effect on biomarkers of RSV@/EZE@ and RSV@/EZE@ vs. simvastatin @ mg and @ mg plus EZE@ ( SIM@/EZE@ and SIM@/EZE@ ) in patients with coronary heart disease ( CHD ) or CHD risk equivalent .